A Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Pharmacokinetics of QAW039 in Steroid-free Patients With Mild to Moderate Persistent Asthma.

Trial Profile

A Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Pharmacokinetics of QAW039 in Steroid-free Patients With Mild to Moderate Persistent Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Fevipiprant (Primary) ; Fluticasone propionate (Primary)
  • Indications Allergic asthma
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 30 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Mar 2012 Additional trial locations (Bulgaria, Hungary, Poland) added as reported by European Clinical Trials Database.
    • 17 Mar 2012 This trial is recruiting in Belgium, Hungary and has been discontinued in Germany, Bulgaria and completed in Poland.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top